Insulin Reduces the Efficacy of Vemurafenib and Trametinib in Melanoma Cells.
Marta OsrodekMichal RozanskiMałgorzata CzyżPublished in: Cancer management and research (2020)
Our results demonstrate the role of insulin in reducing the efficacy of vemurafenib and trametinib. This needs clinical assessment.